Company / Current Liabilities per Share
AVADEL PHARMACEUTICALS PLC Current Liabilities per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.51
FY2024
5-year range
$0.28 / $0.93
FY2020-FY2024
Trend
+11.7%
vs FY2023
Sector context
#155 of 210
Health Care
What the data says
At $0.51, AVADEL PHARMACEUTICALS PLC's current liabilities per share ranks #56 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.28 in FY2020 to $2.07 in FY2017.
Based on SEC 10-K filings.
0.51 in FY2024 with a 5-year CAGR of -11.8%.
Improved from $0.93 to $0.51 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +12.7%
- 5-Year CAGR
- -11.8%
- 10-Year CAGR
- -
Sector benchmark
-97.8% below sector average
Key checks
Key Insights
- In FY2024, current liabilities per share increased 11.7% year-over-year.
- Ranks #155 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2017.
- Lowest current liabilities per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.51 | +11.7% |
| FY2023 | $0.46 | -50.5% |
| FY2022 | $0.93 | +158.8% |
| FY2021 | $0.36 | +30.5% |
| FY2020 | $0.28 | -71.4% |
| FY2019 | $0.96 | -6.4% |
| FY2018 | $1.03 | -50.4% |
| FY2017 | $2.07 | +36.9% |
| FY2016 | $1.51 | +45.9% |
| FY2015 | $1.04 | -47.0% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026